Thus, LRIG1 gene aberrations may be important biological determinants of various aspects of breast cancer biology, and considered as prognostic markers, but the role of this gene as an independent predictor of relapse in breast cancer appears uncertain. This evidence concerns the gene LRIG1 and breast carcinoma.